Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001638599-18-000678

Options or other derivatives

  • Chief Commercial Officer acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Smolinski Stephen · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-06-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +80,000 $12.75 2028-06-14 80,000 80,000 D
Loading xslF345X03/doc4_5479.xml…